Ashland Global Holdings, Inc. ( (ASH) ) has released its Q3 earnings. Here is a breakdown of the information Ashland Global Holdings, Inc. presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Ashland Global Holdings, Inc. is a global additives and specialty ingredients company that serves a variety of consumer and industrial markets, including pharmaceuticals, personal care, and architectural coatings. The company is known for its focus on environmental, social, and governance (ESG) practices.
In its third-quarter fiscal 2025 earnings report, Ashland reported a 15% decline in sales compared to the previous year, totaling $463 million. The company’s performance was impacted by its Portfolio Optimization initiatives, which reduced sales by approximately $53 million. Ashland also reported a net loss of $742 million, primarily due to a non-cash goodwill impairment charge of $706 million.
Key financial metrics included an adjusted EBITDA of $113 million, a 19% decrease from the prior year, and adjusted income from continuing operations of $48 million. The Life Sciences segment experienced a 17% decline in sales, while Personal Care and Specialty Additives also saw declines of 16% and 13%, respectively. Despite these challenges, Ashland maintained strong margins and demonstrated resilience in its core markets.
Looking forward, Ashland has narrowed its full-year fiscal 2025 outlook, expecting sales between $1.825 billion and $1.850 billion and adjusted EBITDA in the range of $400 million to $410 million. The company remains focused on cost savings, operational efficiency, and strategic investments to navigate the current macroeconomic environment and position itself for improved performance in fiscal 2026.